Michael E. Sneed's most recent trade in Wayfair Inc - Ordinary Shares - Class A was a trade of 2,261 Class A Common Stock done . Disclosure was reported to the exchange on Nov. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Wayfair Inc (Class A) | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2025 | 2,261 | 24,543 (0%) | 0% | 0 | Class A Common Stock | |
| Kenvue | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 7,659 | 25,311 | - | - | Deferred Share Units | |
| Wayfair Inc (Class A) | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Nov 2024 | 6,382 | 22,282 (0%) | 0% | 0 | Class A Common Stock | |
| Kenvue | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 9,259 | 17,188 | - | - | Deferred Share Units | |
| Wayfair Inc (Class A) | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Nov 2023 | 5,374 | 15,900 (0%) | 0% | 0 | Class A Common Stock | |
| Kenvue | Michael E. Sneed | Director | Other type of transaction at price $ 0.00 per share. | 23 Aug 2023 | 10,787 | 10,787 | - | - | Common Stock | |
| Kenvue | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 7,620 | 7,620 | - | - | Deferred Share Units | |
| Wayfair Inc (Class A) | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2022 | 8,695 | 10,526 (0%) | 0% | 0 | Class A Common Stock | |
| Wayfair Inc (Class A) | Michael E. Sneed | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 1,037 | 1,831 (0%) | 0% | 0 | Class A Common Stock | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,737 | 0 | - | - | Performance Share Units | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 7,737 | 63,816 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 2,676 | 62,177 (0%) | 0% | 165.6 | 443,012 | Common Stock |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,474 | 0 | - | - | Restricted Share Units | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 1,474 | 65,290 (0%) | 0% | 0 | Common Stock | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.55 per share. | 12 Feb 2021 | 437 | 64,853 (0%) | 0% | 165.5 | 72,345 | Common Stock |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 32,793 | 32,793 | - | - | Employee Stock Options (Right to Buy) | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 7,737 | 7,737 | - | - | Performance Share Units | |
| Johnson & Johnson | Michael E. Sneed | EVP, Global Corp Aff & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2021 | 1,493 | 1,493 | - | - | Restricted Share Units |